secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001493152-25-003982
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen leads NanoSynex bridge round for rapid AST technology
--------------------------------------------------------------

- Qualigen is first investor in NanoSynex's 2025 bridge round of up to $500K.
- NanoSynex's AST halves test time; global market projected at $4.7B by 2027.
- US AST market expected $1.6B; NanoSynex targets EU approval 2027, US 2028.
- NanoSynex holds 4 patents; product has competitive advantages and pipeline.
- CEO says investment supports better antibiotic use and robust diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315225003982/0001493152-25-003982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315225003982/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer